RxDoctor Payments Data

Craig Buchman, MD

Plastic Surgery within the Head & Neck · Saint Louis, MONPI 1538260120

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $332,471 of the $533,603 with a category attached, or 62.3%. Advanced Bionics, LLC accounts for 86.9% of it on its own, with 7 other manufacturers making up the rest.

$533,603in general payments, 2019–2025

Across 101 payments — averaging $5283.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Advanced Bionics, LLC$464K
  • Cochlear Americas$55K
  • Med-el Corporation$6K
  • Iotamotion, Inc.$6K
  • Cochlear Ltd$2K
  • Grace Medical, Inc.$162
  • plus $153 from 2 others
$47,800in research payments, 2019–2025

Across 31 payments — averaging $1541.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cochlear Americas$48K

What the payments were for

  • Royalty or licence$332,47162%
  • Consulting fees$162,74330%
  • Grants$6,0001%
  • Travel & lodging$27,5785%
  • Food & beverage$4,8101%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Advanced Bionics, LLC23$463,752
Cochlear Americas62$55,491
Med-el Corporation6$6,268
Iotamotion, Inc.3$6,224
Cochlear Ltd2$1,552
Grace Medical, Inc.2$162
Medtronic2$136
Olympus America Inc.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few plastic surgery within the head & neck providers in Missourito place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$33,759
Medicare patients
113
Services billed
173

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ofloxacin30$765
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid15$104

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head & neck in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →